Antibody Discovery Market Industry Forecast Report 2024-2035, Featuring Ablexis, ChemPartner, Creative Biolabs, GenScript, Genmab, Harbour BioMed, MabSilico, Nona Biosciences, WuXi Biologics and More
16. Dezember 2024 13:20 ET
|
Research and Markets
Dublin, Dec. 16, 2024 (GLOBE NEWSWIRE) -- The "Antibody Discovery Market Industry Trends and Global Forecasts to 2035, by Type of Service Offered, Antibody Discovery Method, Type of Antibody...
Vaccinex Provides Update on ActivMAb® Platform: Multiple Project Deals and Presentation at SITC
07. November 2024 08:30 ET
|
Vaccinex, Inc.
Partnerships will employ Vaccinex’s ActivMAb® tech. Successful antibody discovery campaigns for cancer immunotherapy to be presented at SITC Nov 9, 2024.
Vaccinex Reports Improved Immunity Correlating with Clinical Benefit of Pepinemab Combination Treatment at Society for Immunotherapy of Cancer’s Annual Meeting
05. November 2024 08:30 ET
|
Vaccinex, Inc.
ROCHESTER, N.Y., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating cancer and neurodegenerative...
Custom Antibody Services Market to Reach $1.4 Billion, Globally, by 2033 at 8.7% CAGR: Allied Market Research
24. September 2024 09:36 ET
|
Allied Analytics LLP
Wilmington, Delaware, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Custom Antibody Services Market by Service (Antibody Development, Antibody Production and...
Antibody Discovery Market Analysis 2018-2023 and Outlook 2024-2033 Featuring Danaher, Eurofins Scientific, Sartorius, Charles River Labs, and Bruker
10. Mai 2024 09:07 ET
|
Research and Markets
Dublin, May 10, 2024 (GLOBE NEWSWIRE) -- The "Antibody Discovery Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The global antibody discovery market has grown...
Vaccinex Reports 2023 Financial Results and Provides Corporate Update
02. April 2024 08:30 ET
|
Vaccinex, Inc.
Expect Topline Data for Randomized SIGNAL-AD Study of Pepinemab for Alzheimer’s Disease in Q3 2024. $17.9 million of new financing in Q4 2023 and Q1 2024.
Antibody Discovery Market Set for Steady Growth, Anticipated to Reach US$ 13.68 Bn by 2030 with a 8.9% CAGR - Insights from Persistence Market Research
22. Januar 2024 06:13 ET
|
Persistence Market Research
New York, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The global antibody discovery market is expected to grow at a rate of 8.9%, reaching a value of US$13.68 billion by 2030, up from US$7.53 billion in 2023....
Antibody Discovery Market Expected to Grow at a CAGR 8.9% from 2023 to 2031 | InsightAce Analytic
19. Dezember 2023 03:41 ET
|
InsightAce Analytic Pvt. LTd.
Jersey City, NJ, Dec. 19, 2023 (GLOBE NEWSWIRE) -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Antibody discovery Market Size, Share & Trends...
Global Antibody Discovery Services Market Set to Soar Past $1.6 Billion by 2023: Aiding Pharmaceutical Efficiency Through Outsourcing
18. Oktober 2023 06:13 ET
|
Research and Markets
Dublin, Oct. 18, 2023 (GLOBE NEWSWIRE) -- The "Antibody Discovery Market: Focus on Services and Platforms - Distribution by Type of Service Offered, Antibody Discovery Method, Type of Antibody...
Telesis Bio to Present at Antibody Engineering and Therapeutics, Europe 2023
06. Juni 2023 03:00 ET
|
Telesis Bio
SAN DIEGO, June 06, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced they will be showcasing their...